NICE recommends AstraZeneca’s dapagliflozin to treat heart failure
The UK’s NICE has issued final draft guidance recommending AstraZeneca’s dapagliflozin (Forxiga) to treat chronic heart failure.
The UK’s NICE has issued final draft guidance recommending AstraZeneca’s dapagliflozin (Forxiga) to treat chronic heart failure.